Warning: The excedrin migraine warning label is inadequate to warn consumers of the risk of medication rebound headache [1] (multiple letters)

Randolph Evans, H. D. Hoffman

Research output: Contribution to journalLetterpeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Warning: The excedrin migraine warning label is inadequate to warn consumers of the risk of medication rebound headache [1] (multiple letters)'. Together they form a unique fingerprint.